In Westlaw Practical Law Q&A, Joshua Oyster and Helen Ryan Analyze Federal Regulation of Psychedelic Therapies
July 17, 2024
July 17, 2024
BOSTON, Massachusetts, July 17 -- Ropes and Gray, a law firm, issued the following news:
In a Westlaw Practical Law Q&A column, life sciences regulatory & compliance partner Joshua Oyster and associate Helen Ryan reviewed the federal legal and regulatory framework that controls the research, approval and marketing of psychedelic drug products.
The Q&A addresses topics such as the types of drugs that are categorized under the term "psychedelic", the . . .
In a Westlaw Practical Law Q&A column, life sciences regulatory & compliance partner Joshua Oyster and associate Helen Ryan reviewed the federal legal and regulatory framework that controls the research, approval and marketing of psychedelic drug products.
The Q&A addresses topics such as the types of drugs that are categorized under the term "psychedelic", the . . .